References
- Yilmaz I, Ermis F, Akata I, et al. A case study: what doses of amanita phalloides and amatoxins are lethal to humans? Wilderness Environ Med. 2015;26:491–496.
- Vetter J. Toxins of Amanita phalloides. Toxicon. 1998;36:13–24.
- Wieland T. The toxic peptides from Amanita mushrooms. Int J Pept Protein Res. 1983;22:257–276.
- Garcia J, Costa VM, Carvalho A, et al. Amanita phalloides poisoning: mechanisms of toxicity and treatment. Food Chem Toxicol. 2015;86:41–55.
- Enjalbert F, Rapior S, Nouguier-Soulé J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40:715–757.
- Diaz JH. Amatoxin-containing mushroom poisonings: species, toxidromes, treatments, and outcomes. Wilderness Environ Med. 2018;29:111–118.
- Ye Y, Liu Z. Management of Amanita phalloides poisoning: a literature review and update. J Crit Care. 2018;46:17–22.
- Yoon E, Babar A, Choudhary M, et al. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 2016;4:131–142.
- Pertile N, Galliani E, Vergerio A, et al. The Amanita phalloides syndrome. Case of a 2-year-old girl. Pediatr Med Chir. 1990;12:411–414.
- Locatelli C, Maccarini D, Travaglia A, et al. Prolonged high-dose n-acetylcysteine treatment of amanita phalloides and chlorinated hydrocarbon poisoning. Pharmacol Res. 1992;26:201.
- Schneider SM, Michelson EA, Vanscoy G. Failure of N-acetylcysteine to reduce alpha amanitin toxicity. J Appl Toxicol. 1992;12:141–142.
- Trakulsrichai S, Sriapha C, Tongpoo A, et al. Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning. Int J Gen Med. 2017;10:395–400.
- Yamada EG, Mohle-Boetani J, Olson KR, et al. Mushroom poisoning due to amatoxin. Northern California, Winter 1996-1997. West J Med. 1998;169:380–384.
- Montanini S, Sinardi D, Pratico C, et al. Use of acetylcysteine as the life-saving antidote in Amanita phalloides (death cap) poisoning. Case report on 11 patients. Arzneimittelforschung. 1999;49:1044–1047.
- Locatelli CA, Petrolini VM, Vecchio S, et al. Outcome in 157 alpha-amanitin-poisoned patients treated with the “Pavia protocol. Toxicol Lett. 2010;196:S91.
- Ahishali E, Boynuegri B, Ozpolat E, et al. Approach to mushroom intoxication and treatment: can we decrease mortality? Clin Res Hepatol Gastroenterol. 2012;36:139–145.
- Grabhorn E, Nielsen D, Hillebrand G, et al. Successful outcome of severe Amanita phalloides poisoning in children. Pediatr Transplant. 2013;17:550–555.
- Bonacini M, Shetler K, Yu I, et al. Features of patients with severe hepatitis due to mushroom poisoning and factors associated with outcome. Clin Gastroenterol Hepatol. 2017;15:776–779.
- Escudie L, Francoz C, Vinel JP, et al. Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol. 2007;46:466–473.
- Bergis D, Friedrich-Rust M, Zeuzem S, et al. Treatment of Amanita phalloides intoxication by fractionated plasma separation and adsorption (Prometheus(R)). J Gastrointestin Liver Dis. 2012;21:171–176.
- Karvellas CJ, Tillman H, Leung AA, et al.; United States Acute Liver Failure Study Group. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int. 2016;36:1043–1050.
- Kieslichova E, Frankova S, Protus M, et al. Acute liver failure due to Amanita phalloides poisoning: therapeutic approach and outcome. Transplant Proc. 2018;50:192–197.
- Akın A, Keşkek ŞÖ, Kılıç DA, et al. The effects of N-acetylcysteine in patients with Amanita phalloides intoxication. J Drug Metabol Toxicol. 2013;04:5.
- Magdalan J, Piotrowska A, Gomułkiewicz A, et al. Influence of commonly used clinical antidotes on antioxidant systems in human hepatocyte culture intoxicated with alpha-amanitin. Hum Exp Toxicol. 2011;30:38–43.
- Zheleva A, Tolekova A, Zhelev M, et al. Free radical reactions might contribute to severe alpha amanitin hepatotoxicity–a hypothesis. Med Hypotheses. 2007;69:361–367.
- Samuni Y, Goldstein S, Dean OM, et al. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta. 2013;1830:4117–4129.
- de Andrade KQ, Moura FA, dos Santos JM, et al. Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of N-acetylcysteine. Int J Mol Sci. 2015;16:30269–30308.
- De Olano J, Wang JJ, Villeneuve E, et al. Current fatality rate of suspected cyclopeptide mushroom poisoning in the United States. Clin Toxicol (Phila). 2020.
- Magdalan J, Ostrowska A, Piotrowska A, et al. Benzylpenicillin, acetylcysteine and silibinin as antidotes in human hepatocytes intoxicated with alpha-amanitin. Exp Toxicol Pathol. 2010;62:367–373.
- Magdalan J, Piotrowska A, Gomułkiewicz A, et al. Benzylpenicyllin and acetylcysteine protection from α-amanitin-induced apoptosis in human hepatocyte cultures. Exp Toxicol Pathol. 2011;63:311–315.
- Tong TC, Hernandez M, Richardson WH, 3rd, et al. Comparative treatment of alpha-amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin in a murine model. Ann Emerg Med. 2007;50:282–288.
- Poucheret P, Fons F, Dore JC, et al. Amatoxin poisoning treatment decision-making: pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis. Toxicon. 2010;55:1338–1345.
- Jander S, Bischoff J, Woodcock BG. Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. Ther Apher. 2000;4:308–312.
- Jan MA, Siddiqui TS, Ahmed N, et al. Mushroom poisoning in children: clinical presentation and outcome. J Ayub Med Coll Abbottabad. 2008;20:99–101.
- Bouchard J, Lavergne V, Roberts DM, et al. Availability and cost of extracorporeal treatments for poisonings and other emergency indications: a worldwide survey. Nephrol Dial Transplant. 2017;32:699–706.
- O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445.
- Bernal W, Donaldson N, Wyncoll D, et al. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 2002;359:558–563.
- Ganzert M, Felgenhauer N, Zilker T. Indication of liver transplantation following amatoxin intoxication. J Hepatol. 2005;42:202–209.
- Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol. 2009;47:81–88. Feb